Form 4 holding
CEO, Director
DMK PHARMACEUTICALS Corp
- Security class
- Common Stock
- Shares / value
- 906,394
- Estimated value
- $547,099
- Report date
- 15 Sep 2023
- Price
- $0.6036
- Ownership
- By Versi Group LLC
Ebrahim Versi - CEO, Director at DMK PHARMACEUTICALS Corp
Issuer-level insider activity
- Role
- CEO, Director
- Issuer ticker
- ADMP
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Ebrahim Versi since 29 Oct 2025
Reported holdings for Ebrahim Versi in DMK PHARMACEUTICALS Corp
Form 4 holding
CEO, Director
DMK PHARMACEUTICALS Corp
- Security class
- Common Stock
- Shares / value
- 8,745
- Estimated value
- $5,278
- Report date
- 15 Sep 2023
- Price
- $0.6036
- Ownership
- Direct
Form 4 holding
CEO, Director
DMK PHARMACEUTICALS Corp
- Security class
- Series E Convertible Preferred Stock
- Shares / value
- 1,212
- Estimated value
- Report date
- 15 Sep 2023
- Price
- Ownership
- By Versi Group LLC
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Ebrahim Versi in DMK PHARMACEUTICALS Corp
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.